TELA Bio (NASDAQ:TELA) Posts Quarterly Earnings Results, Beats Expectations By $0.01 EPS

TELA Bio (NASDAQ:TELA) issued its quarterly earnings results on Thursday. The company reported ($0.23) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.24) by $0.01, Zacks reports. The business had revenue of $17.65 million for the quarter, compared to analysts’ expectations of $23.17 million. TELA Bio had a negative net margin of 60.49% and a negative return on equity of 556.18%. TELA Bio updated its Q1 2025 guidance to EPS and its FY 2025 guidance to EPS.

TELA Bio Stock Down 37.2 %

TELA stock opened at $1.47 on Friday. The company’s 50 day moving average price is $2.56 and its 200 day moving average price is $2.70. The company has a debt-to-equity ratio of 14.22, a quick ratio of 1.81 and a current ratio of 2.62. TELA Bio has a fifty-two week low of $1.28 and a fifty-two week high of $6.50. The firm has a market capitalization of $57.90 million, a price-to-earnings ratio of -0.87 and a beta of 1.10.

Analyst Ratings Changes

A number of research firms recently weighed in on TELA. Canaccord Genuity Group cut their target price on shares of TELA Bio from $12.00 to $7.00 and set a “buy” rating on the stock in a research note on Friday. Piper Sandler lowered shares of TELA Bio from an “overweight” rating to a “neutral” rating and cut their target price for the stock from $5.00 to $2.00 in a research note on Friday.

About TELA Bio

TELA Bio, Inc, a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs.